Catiolanze
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Catiolanze, covering 2024-02-13 to 2024-02-13. Get the full timeline:
Most recent: EMA Authorised: Catiolanze (Latanoprost) — Santen Oy
1 regulatory and trial event tracked for Catiolanze, covering 2024-02-13 to 2024-02-13. Get the full timeline:
Most recent: EMA Authorised: Catiolanze (Latanoprost) — Santen Oy